Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | TPIV100 |
| Trade Name | |
| Synonyms | TPIV-100|TPIV 100 |
| Drug Descriptions |
TPIV100 is a ERBB2 (HER2) vaccine derived from four peptides from ERBB2 (HER2) (NCI Thesaurus). |
| DrugClasses | HER2 (ERBB2) Vaccine 15 |
| CAS Registry Number | NA |
| NCIT ID | C173525 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Ado-trastuzumab emtansine + Sargramostim + TPIV100 | Ado-trastuzumab emtansine Sargramostim TPIV100 | 0 | 1 |
| Sargramostim + TPIV100 + Trastuzumab | Sargramostim TPIV100 Trastuzumab | 0 | 0 |
| TPIV100 | TPIV100 | 0 | 0 |